BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cosmo Pharmaceuticals S.p.A. 

Via C. Colombo 1

Lainate    I – 20020  Italy
Phone: 39-02-9333-7614 Fax: 39-02-9333-7663


SEARCH JOBS




Industry
Pharmaceutical






 Company News
AIMM Therapeutics in Strategic Partnership With Cosmo Pharmaceuticals S.p.A. to Combine Cosmo's Extended Release Technology & AIMM's High Quality Antibodies to Successfully Combat Gastrointestinal Disease 12/19/2012 9:41:54 AM    More...
Cosmo Pharmaceuticals S.p.A. CEO Sees $1.5 Billion Dye Luring Buyer by 2013 9/25/2012 7:55:14 AM    More...
Cosmo Pharmaceuticals S.p.A. Announces Positive Top-Line Results in EU Phase III Clinical Study Evaluating Budesonide MMX In Ulcerative Colitis 11/8/2010 1:00:15 PM    More...
Cosmo Pharmaceuticals S.p.A. Reports Exciting Results in P.O.C. Alopecia Study 10/6/2010 12:43:29 PM    More...
Santarus Inc. (SNTS) and Cosmo Pharmaceuticals S.p.A.'s Anti-Inflammatory Drug Budesonide MMX Meets Late-Stage Goal 9/30/2010 6:54:19 AM    More...
Cosmo Pharmaceuticals S.p.A. Reports Increased Revenues And Operating Profit In First-Half 2010 7/30/2010 12:52:48 PM    More...
Cosmo Pharmaceuticals S.p.A. Reports Shire Pharmaceuticals (SHPGY) Receives LIALDA(R) Paragraph IV Notice Letter from Zydus Pharmaceuticals (USA) Inc. 6/1/2010 12:34:22 PM    More...
Cosmo Pharmaceuticals S.p.A. Reports Good 2009 Results -- Strategic Goals Met - Confident Outlook For 2010 3/22/2010 2:27:52 PM    More...
Cosmo Pharmaceuticals S.p.A. Announces Preliminary End Result Of Its Tender Offer For BioXell S.p.A. 3/1/2010 11:53:19 AM    More...
Cosmo Pharmaceuticals S.p.A.'s CB-03-01 Phase II Pilot Study In Acne Demonstrates Superiority Over Retin A(R) 12/11/2009 10:16:30 AM    More...
123